A carregar...

Efficacy and Safety of Once- versus Twice-Daily Carbamazepine Extended-Release Capsules for the Treatment of Manic Symptoms in Patients with Bipolar I Disorder

Objective: To compare the efficacy and safety of carbamazepine extended-release capsules (CBZ-ERC) administered twice daily (BID) versus once daily for the treatment of manic symptoms associated with bipolar I disorder in adults. Design: This was a Phase IIIb, randomized, double-blind, parallel-grou...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Weisler, Richard H., Kalali, Amir H., Cutler, Andrew J., Gazda, Thomas D., Ginsberg, Lawrence
Formato: Artigo
Idioma:Inglês
Publicado em: Matrix Medical Communications 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3392099/
https://ncbi.nlm.nih.gov/pubmed/22778707
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!